Citadel Advisors’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.7K | Buy |
12,069
+108
| +0.9% | +$454 | ﹤0.01% | 5453 |
|
|
2025
Q1 | $42.2K | Buy |
+11,961
| New | +$42.2K | ﹤0.01% | 5410 |
|
|
2023
Q3 | – | Sell |
-1,484
| Closed | -$19.2K | – | 6516 |
|
|
2023
Q2 | $19.2K | Buy |
+1,484
| New | +$19.2K | ﹤0.01% | 5262 |
|
|
2022
Q4 | – | Sell |
-654
| Closed | -$14K | – | 6725 |
|
|
2022
Q3 | $14K | Buy |
+654
| New | +$14K | ﹤0.01% | 5595 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7199 |
|
|
2021
Q3 | – | Sell |
-3,445
| Closed | -$179K | – | 7095 |
|
|
2021
Q2 | $179K | Buy |
3,445
+2,481
| +257% | +$129K | ﹤0.01% | 5645 |
|
|
2021
Q1 | $57K | Sell |
964
-162
| -14% | -$9.58K | ﹤0.01% | 6064 |
|
|
2020
Q4 | $74K | Buy |
1,126
+848
| +305% | +$55.7K | ﹤0.01% | 4767 |
|
|
2020
Q3 | $28K | Buy |
278
+6
| +2% | +$604 | ﹤0.01% | 4490 |
|
|
2020
Q2 | $50K | Buy |
+272
| New | +$50K | ﹤0.01% | 4377 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5130 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5137 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5111 |
|
|
2019
Q1 | – | Sell |
-23
| Closed | -$18K | – | 5028 |
|
|
2018
Q4 | $18K | Buy |
+23
| New | +$18K | ﹤0.01% | 4304 |
|
|
2018
Q2 | – | Sell |
-10
| Closed | -$39K | – | 4594 |
|
|
2018
Q1 | $39K | Buy |
+10
| New | +$39K | ﹤0.01% | 3782 |
|
|
2016
Q3 | – | Sell |
-4
| Closed | -$85K | – | 4084 |
|
|
2016
Q2 | $85K | Buy |
+4
| New | +$85K | ﹤0.01% | 2984 |
|